Copyright Reports & Markets. All rights reserved.

Global LC-MS Solutions in Clinical Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global LC-MS Solutions in Clinical Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Hardware
      • 1.4.3 Software
    • 1.5 Market by Application
      • 1.5.1 Global LC-MS Solutions in Clinical Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 LC-MS Solutions in Clinical Market Size
    • 2.2 LC-MS Solutions in Clinical Growth Trends by Regions
      • 2.2.1 LC-MS Solutions in Clinical Market Size by Regions (2014-2025)
      • 2.2.2 LC-MS Solutions in Clinical Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 LC-MS Solutions in Clinical Market Size by Manufacturers
      • 3.1.1 Global LC-MS Solutions in Clinical Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global LC-MS Solutions in Clinical Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global LC-MS Solutions in Clinical Market Concentration Ratio (CR5 and HHI)
    • 3.2 LC-MS Solutions in Clinical Key Players Head office and Area Served
    • 3.3 Key Players LC-MS Solutions in Clinical Product/Solution/Service
    • 3.4 Date of Enter into LC-MS Solutions in Clinical Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global LC-MS Solutions in Clinical Market Size by Type (2014-2019)
    • 4.2 Global LC-MS Solutions in Clinical Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States LC-MS Solutions in Clinical Market Size (2014-2019)
    • 5.2 LC-MS Solutions in Clinical Key Players in United States
    • 5.3 United States LC-MS Solutions in Clinical Market Size by Type
    • 5.4 United States LC-MS Solutions in Clinical Market Size by Application

    6 Europe

    • 6.1 Europe LC-MS Solutions in Clinical Market Size (2014-2019)
    • 6.2 LC-MS Solutions in Clinical Key Players in Europe
    • 6.3 Europe LC-MS Solutions in Clinical Market Size by Type
    • 6.4 Europe LC-MS Solutions in Clinical Market Size by Application

    7 China

    • 7.1 China LC-MS Solutions in Clinical Market Size (2014-2019)
    • 7.2 LC-MS Solutions in Clinical Key Players in China
    • 7.3 China LC-MS Solutions in Clinical Market Size by Type
    • 7.4 China LC-MS Solutions in Clinical Market Size by Application

    8 Japan

    • 8.1 Japan LC-MS Solutions in Clinical Market Size (2014-2019)
    • 8.2 LC-MS Solutions in Clinical Key Players in Japan
    • 8.3 Japan LC-MS Solutions in Clinical Market Size by Type
    • 8.4 Japan LC-MS Solutions in Clinical Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia LC-MS Solutions in Clinical Market Size (2014-2019)
    • 9.2 LC-MS Solutions in Clinical Key Players in Southeast Asia
    • 9.3 Southeast Asia LC-MS Solutions in Clinical Market Size by Type
    • 9.4 Southeast Asia LC-MS Solutions in Clinical Market Size by Application

    10 India

    • 10.1 India LC-MS Solutions in Clinical Market Size (2014-2019)
    • 10.2 LC-MS Solutions in Clinical Key Players in India
    • 10.3 India LC-MS Solutions in Clinical Market Size by Type
    • 10.4 India LC-MS Solutions in Clinical Market Size by Application

    11 Central & South America

    • 11.1 Central & South America LC-MS Solutions in Clinical Market Size (2014-2019)
    • 11.2 LC-MS Solutions in Clinical Key Players in Central & South America
    • 11.3 Central & South America LC-MS Solutions in Clinical Market Size by Type
    • 11.4 Central & South America LC-MS Solutions in Clinical Market Size by Application

    12 International Players Profiles

    • 12.1 SCIEX
      • 12.1.1 SCIEX Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 LC-MS Solutions in Clinical Introduction
      • 12.1.4 SCIEX Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.1.5 SCIEX Recent Development
    • 12.2 Agilent Technologies
      • 12.2.1 Agilent Technologies Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 LC-MS Solutions in Clinical Introduction
      • 12.2.4 Agilent Technologies Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.2.5 Agilent Technologies Recent Development
    • 12.3 Thermo Fisher Scientific
      • 12.3.1 Thermo Fisher Scientific Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 LC-MS Solutions in Clinical Introduction
      • 12.3.4 Thermo Fisher Scientific Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.3.5 Thermo Fisher Scientific Recent Development
    • 12.4 PerkinElmer
      • 12.4.1 PerkinElmer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 LC-MS Solutions in Clinical Introduction
      • 12.4.4 PerkinElmer Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.4.5 PerkinElmer Recent Development
    • 12.5 Shimadzu
      • 12.5.1 Shimadzu Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 LC-MS Solutions in Clinical Introduction
      • 12.5.4 Shimadzu Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.5.5 Shimadzu Recent Development
    • 12.6 Agena Bioscience
      • 12.6.1 Agena Bioscience Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 LC-MS Solutions in Clinical Introduction
      • 12.6.4 Agena Bioscience Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.6.5 Agena Bioscience Recent Development
    • 12.7 Beckman Coulter
      • 12.7.1 Beckman Coulter Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 LC-MS Solutions in Clinical Introduction
      • 12.7.4 Beckman Coulter Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.7.5 Beckman Coulter Recent Development
    • 12.8 Waters
      • 12.8.1 Waters Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 LC-MS Solutions in Clinical Introduction
      • 12.8.4 Waters Revenue in LC-MS Solutions in Clinical Business (2014-2019)
      • 12.8.5 Waters Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Liquid chromatography-mass spectrometry (LC-MS) is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography (or HPLC) with the mass analysis capabilities of mass spectrometry (MS).
      In 2018, the global LC-MS Solutions in Clinical market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global LC-MS Solutions in Clinical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the LC-MS Solutions in Clinical development in United States, Europe and China.

      The key players covered in this study
      SCIEX
      Agilent Technologies
      Thermo Fisher Scientific
      PerkinElmer
      Shimadzu
      Agena Bioscience
      Beckman Coulter
      Waters

      Market segment by Type, the product can be split into
      Hardware
      Software

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global LC-MS Solutions in Clinical status, future forecast, growth opportunity, key market and key players.
      To present the LC-MS Solutions in Clinical development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of LC-MS Solutions in Clinical are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now